You may have noticed we haven't updated the TrialsTracker in a while due to some technical issues.
Well good news! Those have been fixed now and you can expect regular updates to resume moving forward!
https://t.co/eJzrePoQMy
WHO highlighting best practice for transparency of trials aligned with revised Dec of Helsinki. Trialists should:
-Prospectively register
-Report within 12 months of completion
-Share results with participants
-Plan to responsibly share trial data
https://t.co/cHRmxVjNHV
Just a note, the https://t.co/697ySuNF2U had not been updated in some time as we needed to make some updates to our software to account for the new https://t.co/lsTVFdnGqW website. Those have now been made at the data is once again current!
WE ARE HIRING!
A prestigious fellowship at @JesusOxford working with us on your own projects around epidemiology, open science, research software engineering and all our usual obsessions! @BennettOxford@OpenSAFELY@openprescribing@FDAAAtracker and more
https://t.co/ENhR6bOfCF
WE ARE HIRING
Junior Research Fellow with college affiliation. That means meals and rich social/intellectual community on top of 3 years with the mighty team that builds @OpenSAFELY@FDAAAtracker@openprescribing Come change the world through data and tools!
Come and work with us. This is an unprecedentedly awesome job. Three years with the team that builds @OpenSAFELY@FDAAAtracker@openprescribing AND Oxford college affiliation, with all the dinners and discursive chats across disciplines that entails!
ICYMI, I had two pieces on pre-registration come out last week with a bunch of wonderful co-authors.
Primer on Registration in @BMJ_EBM: https://t.co/VkWSaoUoUf
Editorial on UK Registration in @bmj_latest: https://t.co/F2OMkVZOwn
In news probably only a handful of people care about, but drove me crazy, https://t.co/o2fspeflFr is finally closing a loophole that let people submit delays of results for good cause much later than should be allowed under FDAAA @reshmagar@TranspariMED@DeborahZarin
Consistent with our findings from the @FDAAAtracker on sponsor size being a major predictor of FDAAA compliance
Here: https://t.co/W4PH7jsxRx
And here: https://t.co/aRZxC2wdWU
And consistent with the EU as well here: https://t.co/dDOVifD9gv
My group in Oxford has published LOTS on who does, and doesn't, report their clinical trial results. But what about the rest: late registrations, data verification, certificates of delay, document sharing? Our @NDevito1 lashes detail in @JAMAInternalMed https://t.co/mRFjgGo21A
I'll shout more about this when it isn't Friday evening but my preprint on COVID trial reporting with @PeterRolandG and @maiameta@Strech_Da from @questbih is up! Check it out for a weekend read!
@MedecineLibre@TranspariMED You’re thinking of @TrialsTracker which used data from a pre-FDAAA TT project that is no longer being maintained so the bot isn’t active. We haven’t made any bots ourselves.
The @US_FDA are under fire for (again) failing to monitor and enforce on non-compliance with trial reporting rules. Our @FDAAAtracker (in the piece) does the monitoring job fine, and didn't cost much to build: they could use that, or build their own. https://t.co/up1rCcToG7
Pleased to share something I've been working on for the past couple weeks. The newest addition to our https://t.co/ZjD2Hbow7s project:
https://t.co/pbnesg9tvE
Just won (mostly) a court case against @us_fda: agency can no longer exempt certain trial results from reporting on https://t.co/ukinHnhiIt contrary to law (FDAAA). Thx to co-plaintiff @DrPeterLurie & litigators @MFIAclinic@nyulaw @Yale_CRIT. https://t.co/jNXbhtnn3g